ICUI logo

ICU Medical Inc. (ICUI)

$148.43

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ICUI

Market cap

$3.66B

EPS

-0.31

P/E ratio

--

Price to sales

1.57

Dividend yield

--

Beta

0.826176

Price on ICUI

Previous close

$147.22

Today's open

$147.22

Day's range

$145.94 - $148.64

52 week range

$107 - $175.51

Profile about ICUI

CEO

Vivek Jain

Employees

15000

Headquarters

San Clemente, CA

Exchange

Nasdaq Global Select

Shares outstanding

24686660

Issue type

Common Stock

ICUI industries and sectors

Healthcare

Medical Equipment & Supplies

News on ICUI

ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference

SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical's fireside chat will be on Thursday, December 4, 2025 at 10:00 a.m. PT (1:00 p.m. ET). Company management will also be participating in one-on-one meetings on Thursday, December 4, 2025.

news source

GlobeNewsWire • Nov 20, 2025

news preview

ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript

ICU Medical, Inc. ( ICUI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Deirdre Thomson - ICR Inc. Jayson Bedford - Raymond James & Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division Lawrence Solow - CJS Securities, Inc. Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good afternoon, everyone, and welcome to ICU Medical's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that today's event is being recorded.

news source

Seeking Alpha • Nov 7, 2025

news preview

ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025.

news source

GlobeNewsWire • Nov 6, 2025

news preview

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago.

news source

Zacks Investment Research • Nov 7, 2025

news preview

ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.

news source

GlobeNewsWire • Oct 23, 2025

news preview

ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

ICU Medical, Inc. (NASDAQ:ICUI ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 8:30 AM EDT Company Participants Vivek Jain - CEO & Chairman of the Board Presentation Unknown Analyst Did you give me the disclosure? Did you say anything more?

news source

Seeking Alpha • Sep 10, 2025

news preview

FDA Identifies ICU Medical's Plum Duo Recall as Serious Type

ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.

news source

Zacks Investment Research • Sep 1, 2025

news preview

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:

news source

GlobeNewsWire • Aug 21, 2025

news preview

ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript

ICU Medical, Inc. (NASDAQ:ICUI ) Q2 2025 Earnings Call August 7, 2025 4:30 PM ET Company Participants Brian Michael Bonnell - CFO & Treasurer Vivek Jain - CEO & Chairman of the Board Conference Call Participants Charles S. Strauzer - CJS Securities, Inc. Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division Michael Toomey - Jefferies LLC, Research Division Michael Stephen Matson - Needham & Company, LLC, Research Division William Korner - Unidentified Company John Mills - ICR Inc. Operator Good afternoon, everyone, and welcome to today's ICU Medical Second Quarter 2025 Earnings Conference Call.

news source

Seeking Alpha • Aug 10, 2025

news preview

ICU Medical (ICUI) Q2 EPS Jumps 40%

ICU Medical (ICUI 2.40%), a medical device company specializing in infusion therapy and related products, released its second quarter results on August 7, 2025. The most important news from the report was a significant earnings per share (EPS) beat, with adjusted EPS of $2.10 (Non-GAAP) compared to analyst expectations of $1.50, a positive difference of 40.0% (Non-GAAP).

news source

The Motley Fool • Aug 8, 2025

news preview

¹ Disclosures

Get started with M1

Invest in ICU Medical Inc.

Open an M1 investment account to buy and sell ICU Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ICUI on M1